Doxorubicin Hydrochloride, Cyclophosphamide, and Paclitaxel With or Without Bevacizumab in Treating Patients With Lymph Node-Positive or High-Risk, Lymph Node-Negative Breast Cancer
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Kathy D Miller
ECOG-ACRIN Cancer Research Group
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
843 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Instituto Nacional de Enfermedades Neoplasicas
Lima, Peru
- University of Pretoria
Pretoria, South Africa
- Northeast Alabama Regional Medical Center
Anniston, Alabama, United States
- University of Alabama at Birmingham Cancer Center
Birmingham, Alabama, United States
- Providence Hospital
Mobile, Alabama, United States
- Alaska Regional Hospital
Anchorage, Alaska, United States
- Providence Alaska Medical Center
Anchorage, Alaska, United States
- Mayo Clinic in Arizona
Scottsdale, Arizona, United States
- Virginia G Piper Cancer Care-del Camino
Scottsdale, Arizona, United States
- Mercy Hospital Fort Smith
Fort Smith, Arkansas, United States
- University of Arkansas for Medical Sciences
Little Rock, Arkansas, United States
- Kaiser Permanente-Deer Valley Medical Center
Antioch, California, United States
- Pcr Oncology
Arroyo Grande, California, United States
- Alta Bates Summit Medical Center-Herrick Campus
Berkeley, California, United States
- Providence Saint Joseph Medical Center/disney Family Cancer Center
Burbank, California, United States
- Mills-Peninsula Medical Center
Burlingame, California, United States
- East Bay Radiation Oncology Center
Castro Valley, California, United States
- Eden Hospital Medical Center
Castro Valley, California, United States
- Valley Medical Oncology Consultants-Castro Valley
Castro Valley, California, United States
- Bay Area Breast Surgeons Inc
Emeryville, California, United States
- Kaiser Permanente-Fremont
Fremont, California, United States
- Valley Medical Oncology Consultants-Fremont
Fremont, California, United States
- Washington Hospital
Fremont, California, United States
- California Cancer Associates for Research and Excellence (ccare)
Fresno, California, United States
- Glendale Memorial Hospital and Health Center
Glendale, California, United States
- Marin Cancer Care Inc
Greenbrae, California, United States
- Marin General Hospital
Greenbrae, California, United States
- Uc San Diego Moores Cancer Center
La Jolla, California, United States
- Usc / Norris Comprehensive Cancer Center
Los Angeles, California, United States
- Contra Costa Regional Medical Center
Martinez, California, United States
- Fremont - Rideout Cancer Center
Marysville, California, United States
- Community Hospital of Monterey Peninsula
Monterey, California, United States
- El Camino Hospital
Mountain View, California, United States
- Palo Alto Medical Foundation-Camino Division
Mountain View, California, United States
- Sutter Cancer Research Consortium
Novato, California, United States
- Alta Bates Summit Medical Center - Summit Campus
Oakland, California, United States
- Bay Area Tumor Institute
Oakland, California, United States
- Hematology and Oncology Associates-Oakland
Oakland, California, United States
- Kaiser Permanente-Oakland
Oakland, California, United States
- Tom K Lee Inc
Oakland, California, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 2 Nov 2007
- Primary completion
- 7 Jan 2014
- Completion
- 20 Feb 2027
- Last update posted
- 29 May 2026
- Registered enrollment
- 4,994
- Registry id
- NCT00433511
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.